306 related articles for article (PubMed ID: 17076655)
21. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
[TBL] [Abstract][Full Text] [Related]
22. Amyloid imaging in Alzheimer's disease.
Nordberg A
Neuropsychologia; 2008; 46(6):1636-41. PubMed ID: 18468648
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's disease sends the wrong signals--a perspective.
Neve RL
Amyloid; 2008 Mar; 15(1):1-4. PubMed ID: 18266116
[TBL] [Abstract][Full Text] [Related]
24. Variations in the neuropathology of familial Alzheimer's disease.
Shepherd C; McCann H; Halliday GM
Acta Neuropathol; 2009 Jul; 118(1):37-52. PubMed ID: 19306098
[TBL] [Abstract][Full Text] [Related]
25. Interactions between the amyloid and cholinergic mechanisms in Alzheimer's disease.
Pákáski M; Kálmán J
Neurochem Int; 2008 Nov; 53(5):103-11. PubMed ID: 18602955
[TBL] [Abstract][Full Text] [Related]
26. Reanalysis of the first case of Alzheimer's disease.
Graeber MB; Mehraein P
Eur Arch Psychiatry Clin Neurosci; 1999; 249 Suppl 3():10-3. PubMed ID: 10654094
[TBL] [Abstract][Full Text] [Related]
27. Homozygosity for the K variant of BCHE gene increases the risk for development of neurofibrillary pathology but not amyloid deposits at young ages.
Ghebremedhin E; Thal DR; Schultz C; Braak H; Deller T
Acta Neuropathol; 2007 Oct; 114(4):359-63. PubMed ID: 17701416
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's original patient.
Amaducci L
Science; 1996 Oct; 274(5286):328. PubMed ID: 8927984
[No Abstract] [Full Text] [Related]
29. [The lesions of Alzheimer's disease: which therapeutic perspectives?].
Duyckaerts C; Perruchini C; Lebouvier T; Potier MC
Bull Acad Natl Med; 2008 Feb; 192(2):303-18; discussion 318-21. PubMed ID: 18819685
[TBL] [Abstract][Full Text] [Related]
30. Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.
Sipos E; Kurunczi A; Kasza A; Horváth J; Felszeghy K; Laroche S; Toldi J; Párducz A; Penke B; Penke Z
Neuroscience; 2007 Jun; 147(1):28-36. PubMed ID: 17499931
[TBL] [Abstract][Full Text] [Related]
31. [Therapy of Alzheimer disease].
Kovács T
Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
[TBL] [Abstract][Full Text] [Related]
32. A transgenic rat model of Alzheimer's disease with extracellular Abeta deposition.
Flood DG; Lin YG; Lang DM; Trusko SP; Hirsch JD; Savage MJ; Scott RW; Howland DS
Neurobiol Aging; 2009 Jul; 30(7):1078-90. PubMed ID: 18053619
[TBL] [Abstract][Full Text] [Related]
33. Neurofibrillary tangle-predominant dementia: comparison with classical Alzheimer disease.
Jellinger KA; Attems J
Acta Neuropathol; 2007 Feb; 113(2):107-17. PubMed ID: 17089134
[TBL] [Abstract][Full Text] [Related]
34. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway.
Masters CL; Beyreuther K
Brain; 2006 Nov; 129(Pt 11):2823-39. PubMed ID: 17012295
[TBL] [Abstract][Full Text] [Related]
35. Methylene blue and Alzheimer's disease.
Oz M; Lorke DE; Petroianu GA
Biochem Pharmacol; 2009 Oct; 78(8):927-32. PubMed ID: 19433072
[TBL] [Abstract][Full Text] [Related]
36. [Histopathology of Alzheimer's disease].
Yardin C
Morphologie; 2007 Dec; 91(295):199-201. PubMed ID: 18024114
[TBL] [Abstract][Full Text] [Related]
37. Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease.
Montalto MC; Farrar G; Hehir CT
Ann N Y Acad Sci; 2007 Feb; 1097():239-58. PubMed ID: 17413026
[TBL] [Abstract][Full Text] [Related]
38. Non-tau based neuronal degeneration in Alzheimer's disease -- an immunocytochemical and quantitative study in the supragranular layers of the middle temporal neocortex.
van de Nes JA; Nafe R; Schlote W
Brain Res; 2008 Jun; 1213():152-65. PubMed ID: 18455153
[TBL] [Abstract][Full Text] [Related]
39. Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.
Van Broeck B; Van Broeckhoven C; Kumar-Singh S
Neurodegener Dis; 2007; 4(5):349-65. PubMed ID: 17622778
[TBL] [Abstract][Full Text] [Related]
40. Neurofibrillary degeneration in Alzheimer's disease: from molecular mechanisms to identification of drug targets.
Pei JJ; Sjögren M; Winblad B
Curr Opin Psychiatry; 2008 Nov; 21(6):555-61. PubMed ID: 18852562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]